Pioneering AI-Driven Patient Care to Elevate Outcomes and Transform Lives in the Dialysis Space
MIAMI, FL / ACCESSWIRE / November 7, 2023 / Innovative Renal Care (IRC) and DeLorean AI are excited to pioneer a groundbreaking partnership in the field of dialysis and chronic kidney disease, marking a historic milestone in kidney care. This innovative collaboration harnesses the power of artificial intelligence (AI) to revolutionize patient outcomes, redefining the standards of healthcare.
DeLorean AI offers a portfolio of healthcare artificial intelligence products, Medical AI, that addresses end-stage renal disease, chronic kidney disease, diabetes, cardiovascular disease, COPD, and mental health, empowering healthcare providers with data-driven forecasts, insights and efficient decision-making tools. Medical AI and its submodule, Renal AI, are the first AI in the world to be biologically validated and applied to patient health at scale. Their mission is to create transformative solutions that elevate patient outcomes, streamline healthcare operations, and enhance the quality of care across various medical domains.
Innovative Renal Care (IRC), a recognized leader in kidney disease management, is devoted to providing patient-centered solutions that improve the quality of life for individuals dealing with renal conditions. IRC's unwavering commitment to delivering innovative and personalized care has earned them a distinguished reputation in the healthcare industry.
The collaboration between Innovative Renal Care and DeLorean AI will involve the seamless integration of DeLorean AI's advanced Renal AI technology product into Innovative Renal Care's existing healthcare platform. This integration will enable healthcare professionals to access real-time patient data and AI-driven insights, fostering personalized care plans and early intervention.
"DeLorean AI is thrilled to join forces with Innovative Renal Care in our shared mission to transform kidney care. By integrating AI into patient assessments, we open new horizons for healthcare improvement. This pioneering partnership represents our commitment to utilizing advanced AI technology for the betterment of patient lives - A Better Way to Better Care," said Dr. Severance MacLaughlin, CEO of Delorean AI.
This partnership leverages AI to assess patients' current conditions as well, enabling accurate predictions of their health trajectories in the future and empowering healthcare providers to make well-informed decisions for optimal care before a care event occurs.
"We are proud to be at the forefront of innovation in the dialysis space. Our partnership with DeLorean AI will enable a level of prediction in patient care that doesn't exist today. This marks a significant milestone in our commitment to providing the best care for our patients," said Geoffrey Walker, MD, Chief Medical Officer of Innovative Renal Care.
"Innovative Renal Care's unwavering commitment to excellence, combined with DeLorean AI's pioneering innovations, will create a predictive approach to treating patients with end-stage renal disease. We're not merely improving patient outcomes; we're orchestrating a groundbreaking shift in the landscape of dialysis. Together, our mission is to usher in a brighter, healthier future for kidney patients," highlighted Nick Mendez, CEO of Innovative Renal Care.
Contact Information:
Cesar Hernandez
PR Director
[email protected]
813-277-6540
SOURCE: DeLorean AI
Source: Delorean AI